| Search |
|
| Menu |
You are not logged in [Login]
|
|
WARSSWarfarin-Aspirin Recurrent Stroke Study
Ongoing Trial |
| Authors: |
The WARSS, APASS, PICSS, HAS and GENESIS Study Groups |
| Titles: |
The feasibility of a collaborative double- blind study using an anticoagulant |
| References: |
Cerebrovasc Dis 1997;7:100-12 |
| Disease: |
Recurrent ischaemic stroke |
| Purpose: |
To compare the effectiveness of warfarin and aspirin in the prevention of recurrent ischaemic stroke and death |
| Study Design: |
Randomised, double-blind, double-dummy, parallel-group |
| Follow-up: |
2 years |
| Patients: |
Aim 1920 patients, age 30-85 years, with cerebral infarction < 30 days |
| Treatmentregimen: |
Warfarin, to target international normalised ratio 1.4-2.8, plus aspirin placebo, or aspirin, 325 mg/day, plus warfarin placebo |
| Results: |
Not yet available | |
|
